Further, both RPMS and BPMS scores correlate positively with those of PD-L1 signature but negatively with OXPHOS (figure 2e(ii)(iii)), reminiscent of observations of PD-L1 activity being anti-correlated with OXPHOS across carcinomas [39]. The gene discussed is CD274; the disease is carcinoma.